午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >PMX 205
PMX 205
  • PMX 205

PMX 205 NEW

Price Get Latest Price
Package 1mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-07-18

Product Details

Product Name: PMX 205 CAS No.: 514814-49-4
Supply Ability: 10g Release date: 2025/07/18

Product Introduction

Bioactivity

NamePMX 205
DescriptionPMX 205 is an effective complement antagonist of the C5a receptor.
In vitroIn the MTT assay, in 24 h plate, it shows that all groups are significant when compared with negative control group. For the PMX 205 group, the value recorded is between 0.09893 to 0.2465, EP54 group, 0.02724 to 0.1748, and Tamoxifen group, the value recorded in between 0.09880 to 0.2464. Only one group shows a significant result for the 72 h plate, PMX 205 (antagonist group) with the value recorded in between 0.02136 to 0.5322. Only two groups show a significant result for the 48 h plate of incubation time, which are PMX 205 and Tamoxifen. The values recorded are between 0.04987 to 0.3273 and 0.5777 to 0.8551 respectively [1].
In vivoPMX 205 (1 mg/kg/day; SOD1G93A rats; p.o.) administered from two-time points (days 28 and 70) before the onset of major clinical symptoms significantly extends survival time compared with untreated rats (p=0.022, day 28; p=0.015, day 70), without clear differences between the two regimens. Treated animals show reduced astroglial proliferation in the lumbar spinal cord and lower end-stage motor scores. In Tg2576 mice, PMX 205 (20 μg/mL in drinking water, n=17) administered from 12 to 15 months of age significantly reduces fibrillar plaque load and hyperphosphorylated tau (69%) compared to untreated controls (n=11).
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
KeywordsPMX-205 | PMX205 | PMX 205 | C5aR

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$775.00/1mg
VIP5Y
TargetMol Chemicals Inc.
2024-10-23
$1980.00/50mg
VIP1Y
TargetMol Chemicals Inc.
2025-07-16
$0.00/100mg
VIP2Y
Xian confluore Biological Technology Co., Ltd.
2024-03-21
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY